INNOVENT Trademark

Trademark Overview

On Monday, April 16, 2018, a trademark application was filed for INNOVENT with the United States Patent and Trademark Office. The USPTO has given the INNOVENT trademark a serial number of 79234854. The federal status of this trademark filing is REGISTERED as of Tuesday, March 24, 2020. This trademark is owned by Innovent Biologics (Suzhou) Co., Ltd.. The INNOVENT trademark is filed in the Pharmaceutical Products category with the following description:

Medicines for human purposes, namely, antibody preparations, protein preparations, blood preparations, hormones, enzymes, toxoids, organic compounds and hemopoietic growth factors, namely, medicines for the treatment of tumor, ophthalmologic diseases, immunological mediated diseases, metabolic diseases, blood diseases, diabetes, endocrine disease, reproductive system disease, central and peripheral nervous system disease, hereditary diseases, and antiviral drugs; Pharmaceutical preparations, namely, antibody preparations, protein preparation, blood preparations, hormones, enzymes, toxoids, organic compounds and hemopoietic growth factors, namely, medicines for the treatment of tumor, ophthalmologic diseases, immunological mediated diseases, metabolic diseases, blood diseases, diabetes, endocrine disease, reproductive system disease, central and peripheral nervous system disease, hereditary diseases, and antiviral drugs; Vaccines; drugs for medical purposes, namely, antibody preparation...
innovent

General Information

Serial Number79234854
Word MarkINNOVENT
Filing DateMonday, April 16, 2018
Status700 - REGISTERED
Status DateTuesday, March 24, 2020
Registration Number6015574
Registration DateTuesday, March 24, 2020
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 7, 2020

Trademark Statements

Description of MarkThe trademark consists of the English letters of "I", "N", "N", "O", "V", "E", "N" and "T", in which the English letter "O" is designed by two symmetrical arcs. The mark has no particular meaning when taken as a whole.
Goods and ServicesMedicines for human purposes, namely, antibody preparations, protein preparations, blood preparations, hormones, enzymes, toxoids, organic compounds and hemopoietic growth factors, namely, medicines for the treatment of tumor, ophthalmologic diseases, immunological mediated diseases, metabolic diseases, blood diseases, diabetes, endocrine disease, reproductive system disease, central and peripheral nervous system disease, hereditary diseases, and antiviral drugs; Pharmaceutical preparations, namely, antibody preparations, protein preparation, blood preparations, hormones, enzymes, toxoids, organic compounds and hemopoietic growth factors, namely, medicines for the treatment of tumor, ophthalmologic diseases, immunological mediated diseases, metabolic diseases, blood diseases, diabetes, endocrine disease, reproductive system disease, central and peripheral nervous system disease, hereditary diseases, and antiviral drugs; Vaccines; drugs for medical purposes, namely, antibody preparations, protein preparation, blood preparations, hormones, enzymes, toxoids, organic compounds and hemopoietic growth factors, namely, medicines for the treatment of tumor, ophthalmologic diseases, immunological mediated diseases, metabolic diseases, blood diseases, diabetes, endocrine disease, reproductive system disease, central and peripheral nervous system disease, hereditary diseases, and antiviral drugs; Biological preparations for medical purposes, namely, antibody preparations, protein preparation, blood preparations, hormones, enzymes, toxoids, organic compounds and hemopoietic growth factors, namely, medicines for the treatment of tumor, ophthalmologic diseases, immunological mediated diseases, metabolic diseases, blood diseases, diabetes, endocrine disease, reproductive system disease, central and peripheral nervous system disease, hereditary diseases, and antiviral drugs; Diagnostic preparations for medical purposes; Biological tissue cultures for medical purposes; Chemical reagents for medical purposes; all of the aforesaid excluding goods in gaseous form, goods related to nitric oxide, and veterinary products, preparations, reagents, and medicine for animal health
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 2, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameInnovent Biologics (Suzhou) Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCN
Party NameInnovent Biologics (Suzhou) Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCN
Party NameInnovent Biologics (Suzhou) Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCN

Trademark Events

Event DateEvent Description
Friday, July 6, 2018APPLICATION FILING RECEIPT MAILED
Thursday, June 21, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, June 25, 2018LIMITATION FROM ORIGINAL APPLICATION ENTERED
Monday, July 2, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 3, 2018ASSIGNED TO EXAMINER
Friday, August 3, 2018NON-FINAL ACTION WRITTEN
Saturday, August 4, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, September 7, 2018REFUSAL PROCESSED BY IB
Monday, August 20, 2018REFUSAL PROCESSED BY MPU
Monday, August 20, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, December 11, 2018SUSPENSION LETTER WRITTEN
Monday, November 19, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 19, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 19, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 19, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 19, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 21, 2018ASSIGNED TO LIE
Monday, November 26, 2018DATA MODIFICATION COMPLETED
Monday, November 26, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, December 7, 2018LIMITATION OF GOODS RECEIVED FROM IB
Tuesday, December 11, 2018LETTER OF SUSPENSION E-MAILED
Tuesday, December 11, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, October 25, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 12, 2018DATA MODIFICATION COMPLETED
Friday, January 18, 2019LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Tuesday, July 16, 2019SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, August 13, 2019FINAL REFUSAL WRITTEN
Tuesday, August 13, 2019FINAL REFUSAL E-MAILED
Tuesday, August 13, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, October 25, 2019TEAS REQUEST FOR RECONSIDERATION RECEIVED
Saturday, October 26, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 25, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 25, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 28, 2019REPORT UNRESPONSIVE AMENDMENT - COMPLETED
Monday, October 28, 2019NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
Monday, October 28, 2019NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
Tuesday, October 29, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 29, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 18, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 18, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 27, 2019NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Monday, November 18, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 18, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 18, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 27, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 4, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 13, 2019NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, December 4, 2019EXAMINERS AMENDMENT -WRITTEN
Wednesday, December 4, 2019EXAMINERS AMENDMENT E-MAILED
Wednesday, December 4, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, December 4, 2019EXAMINER'S AMENDMENT ENTERED
Wednesday, December 18, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 18, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 18, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, January 3, 2020NOTIFICATION PROCESSED BY IB
Tuesday, January 7, 2020PUBLISHED FOR OPPOSITION
Tuesday, January 7, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 24, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, June 24, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, June 25, 2020NEW REPRESENTATIVE AT IB RECEIVED
Friday, July 10, 2020FINAL DISPOSITION NOTICE SENT TO IB
Monday, March 24, 2025COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, July 31, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, June 25, 2020NEW REPRESENTATIVE AT IB RECEIVED
Friday, July 10, 2020FINAL DISPOSITION PROCESSED

Related Keywords

innovent diseases disease preparations namely system blood medicines antibody drugs endocrine